98 related articles for article (PubMed ID: 15214033)
1. Treatment of neonatal mice with Flt3 ligand leads to changes in dendritic cell subpopulations associated with enhanced IL-12 and IFN-alpha production.
Vollstedt S; O'Keeffe M; Odermatt B; Beat R; Glanzmann B; Riesen M; Shortman K; Suter M
Eur J Immunol; 2004 Jul; 34(7):1849-60. PubMed ID: 15214033
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of intestinal Peyer's patch interferon-alpha producing (plasmacytoid) dendritic cells.
Castellaneta A; Abe M; Morelli AE; Thomson AW
Hum Immunol; 2004 Feb; 65(2):104-13. PubMed ID: 14969765
[TBL] [Abstract][Full Text] [Related]
3. Developmental pathways of dendritic cells in vivo: distinct function, phenotype, and localization of dendritic cell subsets in FLT3 ligand-treated mice.
Pulendran B; Lingappa J; Kennedy MK; Smith J; Teepe M; Rudensky A; Maliszewski CR; Maraskovsky E
J Immunol; 1997 Sep; 159(5):2222-31. PubMed ID: 9278310
[TBL] [Abstract][Full Text] [Related]
4. Intrinsic ability of GM+IL-4 but not Flt3L-induced rat dendritic cells to promote allogeneic T cell hyporesponsiveness.
Taieb A; Breitinger JJ; Unadkat JV; Shufesky WJ; Morelli AE; Thomson AW; Lee WP; Feili-Hariri M
Clin Immunol; 2007 May; 123(2):176-89. PubMed ID: 17276735
[TBL] [Abstract][Full Text] [Related]
5. The long-term but not the short-term antiviral effect of IFN-alpha depends on Flt3 ligand and pDC.
Vollstedt S; O'Keeffe M; Ryf B; Glanzmann B; Hochrein H; Suter M
Eur J Immunol; 2006 May; 36(5):1231-40. PubMed ID: 16639711
[TBL] [Abstract][Full Text] [Related]
6. In vivo administration of flt3 ligand markedly stimulates generation of dendritic cell progenitors from mouse liver.
Drakes ML; Lu L; Subbotin VM; Thomson AW
J Immunol; 1997 Nov; 159(9):4268-78. PubMed ID: 9379022
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus efficiently transduces plasmacytoid dendritic cells resulting in TLR9-dependent maturation and IFN-alpha production.
Basner-Tschakarjan E; Gaffal E; O'Keeffe M; Tormo D; Limmer A; Wagner H; Hochrein H; Tüting T
J Gene Med; 2006 Nov; 8(11):1300-6. PubMed ID: 16952196
[TBL] [Abstract][Full Text] [Related]
8. Flt3 ligand promotes myeloid dendritic cell differentiation of human hematopoietic progenitor cells: possible application for cancer immunotherapy.
Harada S; Kimura T; Fujiki H; Nakagawa H; Ueda Y; Itoh T; Yamagishi H; Sonoda Y
Int J Oncol; 2007 Jun; 30(6):1461-8. PubMed ID: 17487367
[TBL] [Abstract][Full Text] [Related]
9. Interleukin-12 and Flt3 ligand differentially promote dendropoiesis in vivo.
Esche C; Cai Q; Peron JM; Hunter O; Subbotin VM; Lotze MT; Shurin MR
Eur J Immunol; 2000 Sep; 30(9):2565-75. PubMed ID: 11009090
[TBL] [Abstract][Full Text] [Related]
10. FLT3 ligand induces the generation of functionally active dendritic cells in mice.
Shurin MR; Pandharipande PP; Zorina TD; Haluszczak C; Subbotin VM; Hunter O; Brumfield A; Storkus WJ; Maraskovsky E; Lotze MT
Cell Immunol; 1997 Aug; 179(2):174-84. PubMed ID: 9268501
[TBL] [Abstract][Full Text] [Related]
11. Effect of water-soluble proteoglycan isolated from Agaricus blazei on the maturation of murine bone marrow-derived dendritic cells.
Kim GY; Lee MY; Lee HJ; Moon DO; Lee CM; Jin CY; Choi YH; Jeong YK; Chung KT; Lee JY; Choi IH; Park YM
Int Immunopharmacol; 2005 Sep; 5(10):1523-32. PubMed ID: 16023604
[TBL] [Abstract][Full Text] [Related]
12. Selective generation of different dendritic cell precursors from CD34+ cells by interleukin-6 and interleukin-3.
Encabo A; Solves P; Mateu E; Sepúlveda P; Carbonell-Uberos F; Miñana MD
Stem Cells; 2004; 22(5):725-40. PubMed ID: 15342937
[TBL] [Abstract][Full Text] [Related]
13. Efficient stimulation of T cell responses by human IFN-alpha-induced dendritic cells does not require Toll-like receptor triggering.
Bracci L; Schumacher R; Provenzano M; Adamina M; Rosenthal R; Groeper C; Zajac P; Iezzi G; Proietti E; Belardelli F; Spagnoli GC
J Immunother; 2008 Jun; 31(5):466-74. PubMed ID: 18463538
[TBL] [Abstract][Full Text] [Related]
14. FLT3 ligand administration after hematopoietic cell transplantation increases circulating dendritic cell precursors that can be activated by CpG oligodeoxynucleotides to enhance T-cell and natural killer cell function.
Chen W; Chan AS; Dawson AJ; Liang X; Blazar BR; Miller JS
Biol Blood Marrow Transplant; 2005 Jan; 11(1):23-34. PubMed ID: 15625541
[TBL] [Abstract][Full Text] [Related]
15. Dendritic cells derived from TBP-2-deficient mice are defective in inducing T cell responses.
Son A; Nakamura H; Okuyama H; Oka S; Yoshihara E; Liu W; Matsuo Y; Kondo N; Masutani H; Ishii Y; Iyoda T; Inaba K; Yodoi J
Eur J Immunol; 2008 May; 38(5):1358-67. PubMed ID: 18425727
[TBL] [Abstract][Full Text] [Related]
16. Flagellin enhances NK cell proliferation and activation directly and through dendritic cell-NK cell interactions.
Tsujimoto H; Uchida T; Efron PA; Scumpia PO; Verma A; Matsumoto T; Tschoeke SK; Ungaro RF; Ono S; Seki S; Clare-Salzler MJ; Baker HV; Mochizuki H; Ramphal R; Moldawer LL
J Leukoc Biol; 2005 Oct; 78(4):888-97. PubMed ID: 16033815
[TBL] [Abstract][Full Text] [Related]
17. Ethanol consumption modifies dendritic cell antigen presentation in mice.
Heinz R; Waltenbaugh C
Alcohol Clin Exp Res; 2007 Oct; 31(10):1759-71. PubMed ID: 17850646
[TBL] [Abstract][Full Text] [Related]
18. IL-6 produced by type I IFN DC controls IFN-gamma production by regulating the suppressive effect of CD4+ CD25+ regulatory T cells.
Detournay O; Mazouz N; Goldman M; Toungouz M
Hum Immunol; 2005 May; 66(5):460-8. PubMed ID: 15935883
[TBL] [Abstract][Full Text] [Related]
19. Chorionic gonadotropin induces dendritic cells to express a tolerogenic phenotype.
Wan H; Versnel MA; Leijten LM; van Helden-Meeuwsen CG; Fekkes D; Leenen PJ; Khan NA; Benner R; Kiekens RC
J Leukoc Biol; 2008 Apr; 83(4):894-901. PubMed ID: 18171698
[TBL] [Abstract][Full Text] [Related]
20. Dendritic cells from control but not atopic donors respond to contact and respiratory sensitizer treatment in vitro with differential cytokine production and altered stimulatory capacity.
Holden NJ; Bedford PA; McCarthy NE; Marks NA; Ind PW; Jowsey IR; Basketter DA; Knight SC
Clin Exp Allergy; 2008 Jul; 38(7):1148-59. PubMed ID: 18498417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
